CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a novel non-steroidal drug candidate for treating ocular inflammatory diseases, aiming to provide a long-lasting therapeutic effect. It targets uveitic glaucoma and seeks to disrupt the underlying immune mechanisms causing the disease.
Ocular inflammatory diseases – affecting hundreds of millions of people worldwide – impose a significant medical and economic burden on society and can lead to blindness.
Today, corticosteroids are the most common method used to treat ocular non-infectious inflammation of any kind.
Rather than treating the disease itself, however, steroids merely relieve its symptoms, and long-term use can result in devastating consequences.Our bio-inspired drug candidate is a non-steroid.
It approaches inflamma…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
